Clinical Trials Browser

Phase 1/2 × ceritinib × Lymphoid × Clear all

NCT02729961 2019-10-10

Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma

Phase 1/2 Withdrawn

Lymphoma, Large-Cell, Anaplastic